Dot blot for deletion mutation12/28/2023 ![]() US case filed in Utah District Court litigation Source: District Court Jurisdiction: Utah District Court "Unified Patents Litigation Data" by Unified Patents is licensed under a Creative Commons Attribution 4.0 International License. US case filed in California Central District Court litigation Source: District Court Jurisdiction: California Central District Court "Unified Patents Litigation Data" by Unified Patents is licensed under a Creative Commons Attribution 4.0 International License. US case filed in California Northern District Court litigation Source: District Court Jurisdiction: California Northern District Court "Unified Patents Litigation Data" by Unified Patents is licensed under a Creative Commons Attribution 4.0 International License. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GENE LOGIC ACQUISITION CORPORATION Publication of US6492109B1 publication Critical patent/US6492109B1/en Application granted granted Critical Assigned to MYRIAD GENETICS INC. Assigned to GENE LOGIC ACQUISITION CORP reassignment GENE LOGIC ACQUISITION CORP MERGER (SEE DOCUMENT FOR DETAILS). Assignors: THURBER, DENISE B., LESCALLET, JENNIFER L. Priority to US09/158,183 priority Critical patent/US6492109B1/en Application filed by Ore Pharmaceuticals Inc filed Critical Ore Pharmaceuticals Inc Priority to AU93216/98A priority patent/AU9321698A/en Priority to PCT/US1998/019785 priority patent/WO1999015701A1/en Assigned to GENE LOGIC, INC. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Family has litigation Priority claimed from US5959597P external-priority First worldwide family litigation filed litigation Critical (B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License. Original Assignee Ore Pharmaceuticals Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Thurber Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Expired - Lifetime Application number US09/158,183 Inventor Jennifer L. Google Patents Susceptibility mutation 6495delGC of BRCA2ĭownload PDF Info Publication number US6492109B1 US6492109B1 US09/158,183 US15818398A US6492109B1 US 6492109 B1 US6492109 B1 US 6492109B1 US 15818398 A US15818398 A US 15818398A US 6492109 B1 US6492109 B1 US 6492109B1 Authority US United States Prior art keywords sequence oligonucleotide brca2 isolated oligonucleotide seq Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US6492109B1 - Susceptibility mutation 6495delGC of BRCA2 US6492109B1 - Susceptibility mutation 6495delGC of BRCA2 ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |